S L Nightingale. Show Affiliations »
Abstract
Mesh： See more » AlendronateAnti-Bacterial Agents/therapeutic useClarithromycin/therapeutic useConsumer Product SafetyDiphosphonates/administration & dosageDiphosphonates/adverse effectsDrug ApprovalDrug Therapy, CombinationDuodenal Ulcer/drug therapyDuodenal Ulcer/microbiologyEphedrine/adverse effectsEsophageal Diseases/chemically inducedHelicobacter Infections/drug therapyHelicobacter Infections/physiopathologyHelicobacter pyloriIllicit DrugsOmeprazole/therapeutic usePlant Extracts/adverse effectsProduct LabelingRecurrenceUnited StatesUnited States Food and Drug Administration
Substances： See more » Anti-Bacterial AgentsDiphosphonatesIllicit DrugsPlant ExtractsEphedrineClarithromycinOmeprazoleAlendronate
Year: 1996 PMID： 8622234 DOI： 10.1001/jama.275.20.1534
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272